NFKB1 and Miyoshi myopathy: Based on our analyses, we cannot conclude if this increase is due to therapy-mediated positive selection of MM PC with high NFκB signaling, or if NFκB signaling is increased in all surviving MM PC due to treatment-induced activation of the BM microenvironment.